record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundmeta_analysis · manual state transition; placebo-controlled clinical trial where source reports control arm · Homo sapiens
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; placebo-controlled clinical trial where source reports control arm
evidence type
meta_analysis
species
Homo sapiens
evidence spans
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's Disease. — To inform an efficient development of new investigational anti-amyloid beta (anti-Aβ) monoclonal antibodies (mAbs), a modeling-and-simulation-based strategy was proposed. A general...
Bachhav SS; Ponce-Bobadilla AV; Clausznitzer D; Stodtmann S; Xiong H. CPT: pharmacometrics & systems pharmacology 2025. doi:10.1002/psp4.70038 · curator_source · 10.1002/psp4.70038
conditions
Provenance
source title
Bachhav SS; Ponce-Bobadilla AV; Clausznitzer D; Stodtmann S; Xiong H. CPT: pharmacometrics & systems pharmacology 2025. doi:10.1002/psp4.70038
doi
10.1002/psp4.70038
journal
CPT: pharmacometrics & systems pharmacology
authors
Bachhav SS, Ponce-Bobadilla AV, Clausznitzer D, Stodtmann S, Xiong H
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's Disease. — To inform an efficient development of new investigational anti-amyloid beta (anti-Aβ) monoclonal antibodies (mAbs), a modeling-and-simulation-based strategy was proposed. A general...
vs_5fab5fe658ec6e73 · source:Bachhav SS; Ponce-Bobadilla AV; Clausznitzer D; Stodtmann S; Xiong H. CPT: pharmacometrics & systems pharmacology 2025. doi:10.1002/psp4.70038|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_4c5c5a0be32f03bcfinding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_e7b9a755f3ef54f9finding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.